No data available
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.?
cancer profiling, diagnostics
new antibiotics class
Optimum is an international strategic healthcare communications firm, specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. We are experienced and trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, biotech, digital health and healthcare services, large and small.
Watch our Member Showcase Video https://bit.ly/3FFKIIz
Watch our Member Showcase Video https://bit.ly/3FFKIIz
Our Biosciences Team has advised on a wide variety of matters including research and development agreements, patent and know how licences and assignments, manufacturing agreements, bioinformatics, regulatory matters, clinical trials, patent litigation and competition law. The members of the Biosciences Team pride themselves on their responsive, hands-on and pro-active approach. This includes helping to find venture capital finance for clients through the firm's extensive corporate finance network and advising on intellectual property protection and exploitation. Osborne Clarke recognises that biotechnology companies want to deal with a team of specialists whose experience ensures technically accurate and commercial, pragmatic advice.. . Biotechnology agreements, collaborations, research and devleopment agreements, venture capital and other funding arrangements for biotechnology companies. Represented in most major European jurisdictions and in Silicon Valley.. . Bioinformatics, law, European law, research, colllaboration, contract research, intellectual property, patents, financing, competition law, technology transfer, mergers and acquisitions, due diligence, regulatory matters.
No data available
Ovartix is a women’s health drug discovery company that harnesses large-scale human multi-omics data, state-of-the-art cell engineered and animal models to identify, validate and develop next-generation therapeutics for ovary-centric female reproductive disorders, such as infertility and menopause